Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.

Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.

Item
http://www.wikidata.org/entity/Q34977225
Insulin sensitizing effects of oligomannuronate-chromium (III) complexes in C2C12 skeletal muscle cellsThe effects of propionate and valerate on insulin responsiveness for glucose uptake in 3T3-L1 adipocytes and C2C12 myotubes via G protein-coupled receptor 41Management of type 2 diabetes mellitus. Role of thiazolidinediones.Troglitazone and Δ2Troglitazone enhance adiponectin expression in monocytes/macrophages through the AMP-activated protein kinase pathway.Therapeutic effects of troglitazone in experimental chronic pancreatitis in miceFucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte CellsPatterns of use of insulin-sensitizing agents among diabetic, borderline diabetic and non-diabetic women in the National Health and Nutrition Examination Surveys.An observational study of the effect of two thiazolidinediones on blood lipid levels: Rosiglitazone and pioglitazone in routine clinical practicePaprika Pigments Attenuate Obesity-Induced Inflammation in 3T3-L1 Adipocytes.Promoting the effect of chemical constituents from the flowers of Poacynum hendersonii on adipogenesis in 3T3-L1 cells.Adipogenic effects of piperlonguminine in 3T3-L1 cells and plasma concentrations of several amide constituents from Piper chaba extracts after treatment of mice.Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling.Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury.Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone.Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.
P2860

Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.

Item
http://www.wikidata.org/entity/Q34977225
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@ast
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@en
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@nl
type
label
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@ast
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@en
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@nl
prefLabel
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@ast
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@en
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Troglitazone: the discovery an ...... t of Type 2 diabetes mellitus.
@en
P2093
P304
P31
P356
10.1016/S0169-409X(02)00093-5
P407
P433
P478
P577
P698
P921